Consolidated Investment Products (Tables)
|
6 Months Ended |
Mar. 31, 2024 |
Consolidated Investment Products [Abstract] |
|
Schedule of balances of CIPs |
The balances related to CIPs included in the Company’s consolidated balance sheets were as follows: | | | | | | | | | | | | | | | (in millions) | | March 31, 2024 | | September 30, 2023 | Assets | | | | | Cash and cash equivalents | | $ | 824.1 | | | $ | 716.0 | | Receivables | | 185.6 | | | 166.7 | | Investments, at fair value | | 11,149.1 | | | 9,637.2 | | Total Assets | | $ | 12,158.8 | | | $ | 10,519.9 | | | | | | | Liabilities | | | | | Accounts payable and accrued expenses | | $ | 744.4 | | | $ | 349.7 | | Debt | | 9,131.0 | | | 8,231.8 | | Other liabilities | | 49.2 | | | 25.1 | | Total liabilities | | 9,924.6 | | | 8,606.6 | | Redeemable Noncontrolling Interests | | 643.5 | | | 580.1 | | Stockholders’ Equity | | | | | Franklin Resources, Inc.’s interests | | 1,255.5 | | | 1,033.9 | | Nonredeemable noncontrolling interests | | 335.2 | | | 299.3 | | Total stockholders’ equity | | 1,590.7 | | | 1,333.2 | | Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity | | $ | 12,158.8 | | | $ | 10,519.9 | |
|
Schedule of assets measured at fair value on a recurring basis |
Assets of CIPs measured at fair value on a recurring basis were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Level 1 | | Level 2 | | Level 3 | | NAV as a Practical Expedient | | Total | as of March 31, 2024 | | | | | | Assets | | | | | | | | | | | Cash and cash equivalents of CLOs | | $ | 548.3 | | | $ | — | | | $ | — | | | $ | — | | | $ | 548.3 | | Receivables of CLOs | | — | | | 76.1 | | | — | | | — | | | 76.1 | | Investments | | | | | | | | | | | Equity and debt securities | | 307.7 | | | 865.8 | | | 591.0 | | | 160.2 | | | 1,924.7 | | Loans | | — | | | 9,224.4 | | | — | | | — | | | 9,224.4 | | | | | | | | | | | | | Total Assets Measured at Fair Value | | $ | 856.0 | | | $ | 10,166.3 | | | $ | 591.0 | | | $ | 160.2 | | | $ | 11,773.5 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Level 1 | | Level 2 | | Level 3 | | NAV as a Practical Expedient | | Total | as of September 30, 2023 | | | | | | Assets | | | | | | | | | | | Cash and cash equivalents of CLOs | | $ | 352.3 | | | $ | — | | | $ | — | | | $ | — | | | $ | 352.3 | | Receivables of CLOs | | — | | | 116.7 | | | — | | | — | | | 116.7 | | Investments | | | | | | | | | | | Equity and debt securities | | 210.9 | | | 642.6 | | | 584.9 | | | 154.0 | | | 1,592.4 | | Loans | | — | | | 8,044.8 | | | — | | | — | | | 8,044.8 | | | | | | | | | | | | | Total Assets Measured at Fair Value | | $ | 563.2 | | | $ | 8,804.1 | | | $ | 584.9 | | | $ | 154.0 | | | $ | 10,106.2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Schedule of CIPs investments measured at NAV |
Investments for which fair value was estimated using reported NAV as a practical expedient consist of a redeemable U.S. equity fund, a redeemable global hedge fund and nonredeemable private debt funds. These investments were as follows: | | | | | | | | | | | | | | | (in millions) | | March 31, 2024 | | September 30, 2023 | Nonredeemable investments1 | | | | | | | | | | Investments with unknown liquidation periods | | $ | 23.9 | | | $ | 21.8 | | | | | | | Redeemable investments2 | | 136.3 | | | 132.2 | | | | | | | | | | | |
|
Schedule of changes in Level 3 assets of CIPs |
Changes in Level 3 assets were as follows: | | | | | | | | | | | | | | | (in millions) | | Equity and Debt Securities | | | | | | | for the three months ended March 31, 2024 | Balance at January 1, 2024 | | $ | 551.5 | | | | | | | | Acquisition | | 29.6 | | | | | | | | Losses included in investment and other income of consolidated investment products, net | | (0.1) | | | | | | | | Purchases | | 22.8 | | | | | | | | Sales | | (0.3) | | | | | | | | Net deconsolidations | | (12.5) | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2024 | | $ | 591.0 | | | | | | | | Change in unrealized gains included in net income relating to assets held at March 31, 2024 | | $ | — | | | | | | | |
| | | | | | | | | | | | | | | (in millions) | | Equity and Debt Securities | | | | | | | for the six months ended March 31, 2024 | Balance at October 1, 2023 | | $ | 584.9 | | | | | | | | Acquisition | | 29.6 | | | | | | | | Losses included in investment and other income of consolidated investment products, net | | (38.2) | | | | | | | | Purchases | | 26.6 | | | | | | | | Sales | | (0.5) | | | | | | | | Net deconsolidations | | (12.5) | | | | | | | | Transfers into Level 3 | | 1.1 | | | | | | | | | | | | | | | | | Balance at March 31, 2024 | | $ | 591.0 | | | | | | | | Change in unrealized losses included in net income relating to assets held at March 31, 2024 | | $ | (37.6) | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Equity and Debt Securities | | Real Estate | | Loans | | Total Level 3 Assets | for the three months ended March 31, 2023 | Balance at January 1, 2023 | | $ | 555.8 | | | $ | 358.0 | | | $ | 64.7 | | | $ | 978.5 | | Losses included in investment and other income of consolidated investment products, net | | (18.4) | | | (12.7) | | | — | | | (31.1) | | Purchases | | 13.5 | | | 0.4 | | | 31.1 | | | 45.0 | | Sales | | (19.4) | | | — | | | — | | | (19.4) | | Net (deconsolidations) consolidations | | 7.5 | | | (345.7) | | | (90.5) | | | (428.7) | | Transfers into Level 3 | | — | | | — | | | 3.1 | | | 3.1 | | Transfers out of Level 3 | | — | | | — | | | (5.3) | | | (5.3) | | | | | | | | | | | Balance at March 31, 2023 | | $ | 539.0 | | | $ | — | | | $ | 3.1 | | | $ | 542.1 | | Change in unrealized losses included in net income relating to assets held at March 31, 2023 | | $ | (25.0) | | | $ | — | | | $ | — | | | $ | (25.0) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Equity and Debt Securities | | Real Estate | | Loans | | Total Level 3 Assets | for the six months ended March 31, 2023 | Balance at October 1, 2022 | | $ | 555.8 | | | $ | 268.6 | | | $ | 239.4 | | | $ | 1,063.8 | | Gains (losses) included in investment and other income of consolidated investment products, net | | (24.7) | | | (9.0) | | | 0.1 | | | (33.6) | | Purchases | | 22.5 | | | 86.1 | | | 58.6 | | | 167.2 | | Sales | | (25.0) | | | — | | | (0.2) | | | (25.2) | | Net (deconsolidations) consolidations | | 10.4 | | | (345.7) | | | (292.6) | | | (627.9) | | Transfers into Level 3 | | — | | | — | | | 3.1 | | | 3.1 | | Transfers out of Level 3 | | — | | | — | | | (5.3) | | | (5.3) | | | | | | | | | | | Balance at March 31, 2023 | | $ | 539.0 | | | $ | — | | | $ | 3.1 | | | $ | 542.1 | | Change in unrealized losses included in net income relating to assets held at March 31, 2023 | | $ | (22.3) | | | $ | — | | | $ | — | | | $ | (22.3) | |
|
Schedule of valuation techniques and significant unobservable inputs used in Level 3 fair value measurements |
Valuation techniques and significant unobservable inputs used in Level 3 fair value measurements were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | | | | | | | | as of March 31, 2024 | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range (Weighted Average1) | Equity and debt securities | | $ | 298.3 | | | Market pricing | | Private sale pricing | | $0.37–$1,000.00 ($60.33) per share | | | Discount for lack of marketability | | 18.8%–24.5% (22.2%) | | 248.7 | | | Market comparable companies | | Enterprise value/ Revenue multiple | | 1.5–22.4 (15.1) | | | | Discount for lack of marketability | | 7.4%–9.9% (8.8%) | | 44.0 | | | Discounted cash flow | | Discount rate | | 6.4% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | | | | | | | | as of September 30, 2023 | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range (Weighted Average1) | Equity and debt securities | | $ | 346.0 | | | Market pricing | | Private sale pricing | | $0.01–$1,000.00 ($23.88) per share | | | | Discount for lack of marketability | | 21.9% | | 238.9 | | Market comparable companies | | Enterprise value/ Revenue multiple | | 11.4–13.5 (12.1) | Discount for lack of marketability | | 11.2%–13.6% (12.2%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Schedule of financial instruments of CIPs not measured at fair value |
Financial instruments of CIPs that were not measured at fair value were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Fair Value Level | | March 31, 2024 | | September 30, 2023 | | | Carrying Value | | Estimated Fair Value | | Carrying Value | | Estimated Fair Value | Financial Asset | | | | | | | | | | | Cash and cash equivalents | | 1 | | $ | 275.8 | | | $ | 275.8 | | | $ | 363.7 | | | $ | 363.7 | | | | | | | | | | | | | Financial Liabilities | | | | | | | | | | | Debt of CLOs1 | | 2 or 3 | | $ | 9,116.0 | | | $ | 8,867.4 | | | $ | 8,210.0 | | | $ | 8,013.2 | | Other debt | | 2 or 3 | | 15.0 | | | 15.0 | | | 21.8 | | | 8.6 | | | | | | | | | | | | |
|
Schedule of debt of CIPs |
Debt of CIPs consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2024 | | September 30, 2023 | (in millions) | | Amount | | Weighted- Average Effective Interest Rate | | Amount | | Weighted- Average Effective Interest Rate | Debt of CLOs | | $ | 9,116.0 | | | 7.54% | | $ | 8,210.0 | | | 7.12% | Other debt | | 15.0 | | | 5.57% | | 21.8 | | | 6.00% | Total | | $ | 9,131.0 | | | | | $ | 8,231.8 | | | |
|
Schedule of contractual maturities for debt of CIPs |
The contractual maturities for the debt of CIPs at March 31, 2024 were as follows: | | | | | | | | | (in millions) | | | for the fiscal years ending September 30, | Amount | 2024 (remainder of year) | | $ | 191.5 | | 2025 | | 15.0 | | 2026 | | — | | 2027 | | — | | 2028 | | — | | Thereafter | | 8,924.5 | | Total | | $ | 9,131.0 | |
|
Schedule of unpaid principal balance and fair value of investments of CLOs |
The unpaid principal balance and fair value of the investments of CLOs were as follows: | | | | | | | | | | | | | | | (in millions) | | March 31, 2024 | | September 30, 2023 | Unpaid principal balance | | $ | 9,365.9 | | | $ | 8,317.5 | | Difference between unpaid principal balance and fair value | | 22.4 | | | (120.7) | | Fair Value | | $ | 9,388.3 | | | $ | 8,196.8 | |
|